Global Immune Technologies Completes Securities Agreement With Primedical International Limited And Elects New Board Of Directors; New Management Well Positioned To Lead Company To Growth In The Ambulatory Cardiac Monitoring Market
Global Immune Technologies, Inc. (OTCBB:GIMU) is pleased to advise that it has signed a Securities Exchange Agreement (SEA) proposing a reverse merger with Primedical International Limited (PML). The combined company, to be renamed Primedical International Holdings, Inc. (Primedical), intends to be a leading provider of telemedicine and remote ambulatory monitoring services.